IL97758A0 - Epithelins:cysteine-rich growth modulating proteins - Google Patents

Epithelins:cysteine-rich growth modulating proteins

Info

Publication number
IL97758A0
IL97758A0 IL97758A IL9775891A IL97758A0 IL 97758 A0 IL97758 A0 IL 97758A0 IL 97758 A IL97758 A IL 97758A IL 9775891 A IL9775891 A IL 9775891A IL 97758 A0 IL97758 A0 IL 97758A0
Authority
IL
Israel
Prior art keywords
epithelin
growth
epithelins
purified
precursor
Prior art date
Application number
IL97758A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL97758A0 publication Critical patent/IL97758A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97758A 1990-04-03 1991-04-03 Epithelins:cysteine-rich growth modulating proteins IL97758A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50450890A 1990-04-03 1990-04-03
US07/668,648 US5416192A (en) 1990-04-03 1991-03-13 Epithelins: novel cysteine-rich growth modulating proteins

Publications (1)

Publication Number Publication Date
IL97758A0 true IL97758A0 (en) 1992-06-21

Family

ID=27054846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97758A IL97758A0 (en) 1990-04-03 1991-04-03 Epithelins:cysteine-rich growth modulating proteins

Country Status (15)

Country Link
US (3) US5416192A (de)
EP (1) EP0527806B1 (de)
CN (1) CN1058782A (de)
AT (1) ATE162549T1 (de)
AU (1) AU639787B2 (de)
CA (1) CA2079218A1 (de)
CS (1) CS91791A3 (de)
DE (1) DE69128779D1 (de)
GR (1) GR3026263T3 (de)
HU (1) HUT63438A (de)
IE (1) IE911117A1 (de)
IL (1) IL97758A0 (de)
NZ (1) NZ237661A (de)
OA (1) OA09711A (de)
WO (1) WO1991015510A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015195A1 (en) * 1992-02-03 1993-08-05 Samuel Solomon Granulins from leukocytes
WO2000055319A1 (en) * 1999-03-12 2000-09-21 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2000075327A1 (en) * 1999-06-02 2000-12-14 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US6720159B1 (en) * 1997-12-16 2004-04-13 A&G Pharmaceutical, Inc. 88KDA tumorigenic growth factor and antagonists
US8512960B2 (en) * 1997-05-23 2013-08-20 A&G Pharmaceutical, Inc. 88kDa tumorigenic growth factor and antagonists
US20030215445A1 (en) * 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6309826B1 (en) * 1997-05-23 2001-10-30 Ginette Serrero 88kDa tumorigenic growth factor and antagonists
US6881548B2 (en) 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US7091047B2 (en) 1997-05-23 2006-08-15 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity
JP2002527452A (ja) * 1998-10-13 2002-08-27 ジェネンテック・インコーポレーテッド 腫瘍性細胞成長阻害のための組成物及び方法
EP1135491A2 (de) * 1998-12-01 2001-09-26 Genentech, Inc. Verfahren und zusammensetzungen zur inhibierung des neoplastischen zellwachstums
IL143031A0 (en) * 1998-12-22 2002-04-21 Genentech Inc Methods and compositions for inhibiting neoplastic cell growth
CA2450402A1 (en) * 1998-12-22 2000-06-29 Genentech, Inc. Methods and compositions for inhibiting cancer cell growth comprising pro224
AU2399300A (en) * 1999-03-08 2000-09-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
AU2215300A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
EP1873244A3 (de) * 1999-06-02 2008-04-02 Genentech, Inc. Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
DK1185648T3 (da) * 1999-06-02 2007-07-30 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
JP4280444B2 (ja) * 2000-01-06 2009-06-17 ジェネンテック・インコーポレーテッド 腫瘍性細胞成長阻害のための組成物及び方法
CA2400376A1 (en) * 2000-02-28 2001-09-07 Linda M. Liau Methods for detection and treatment of neural cancers
US6872703B2 (en) * 2000-06-07 2005-03-29 Ajinomoto Co., Inc. Insulin receptor-related receptor binding protein
AUPR673001A0 (en) * 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
WO2003074662A2 (en) * 2002-03-01 2003-09-12 Exelixis, Inc. SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
DE60334499D1 (de) * 2003-02-26 2010-11-18 A & G Pharmaceuticals Inc Verfahren zur erhöhung der ausbreitung von b-zellen
CA2530582C (en) * 2003-06-23 2014-09-09 A&G Pharmaceutical, Inc. Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
US20070065887A1 (en) * 2003-07-21 2007-03-22 Kinch Michael S Diagnosis of pre-cancerous conditions using pcdgf agents
EP1660010B1 (de) * 2003-08-01 2013-07-24 A & G Pharmaceutical, Inc. Zusammensetzungen und verfahren zur wiederherstellung der empfänglichkeit für eine behandlung mit her2-antagonisten
CN107085108A (zh) 2008-09-05 2017-08-22 A&G药品公司 诊断癌症和确定癌症患者的总体生存和无病生存的方法
US8362218B2 (en) 2009-04-17 2013-01-29 New York University School Of Medicine Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
US9913399B2 (en) 2015-02-09 2018-03-06 Dell Products, Lp System and method for wireless rack management controller communication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590003A (en) * 1984-03-23 1986-05-20 Oncogen Platelet related growth regulator

Also Published As

Publication number Publication date
NZ237661A (en) 1993-07-27
CS91791A3 (en) 1992-06-17
US5416192A (en) 1995-05-16
GR3026263T3 (en) 1998-05-29
DE69128779D1 (de) 1998-02-26
HUT63438A (en) 1993-08-30
US5965723A (en) 1999-10-12
EP0527806B1 (de) 1998-01-21
US5885961A (en) 1999-03-23
ATE162549T1 (de) 1998-02-15
CN1058782A (zh) 1992-02-19
AU639787B2 (en) 1993-08-05
WO1991015510A1 (en) 1991-10-17
OA09711A (en) 1993-08-30
EP0527806A4 (en) 1993-05-05
IE911117A1 (en) 1991-10-09
EP0527806A1 (de) 1993-02-24
AU7744791A (en) 1991-10-30
HU9203137D0 (en) 1992-12-28
CA2079218A1 (en) 1991-10-04

Similar Documents

Publication Publication Date Title
OA09711A (en) Epithelins: novel cysteine-rich growth modulating proteins.
ATE194658T1 (de) Das dorsalgewebe beeinflussender faktor
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
DE69119879T2 (de) Epitheliocytenwachstumsbeschleuniger
DE278776T1 (de) Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein.
CA2223433A1 (en) Ob protein compositions and methods
AU8149491A (en) New forms of colony stimulating factor-1
EP0404034A3 (de) DNS und ihre Verwendung
EP0218531A3 (de) Immunogenische Peptide von menschlichem Interleukin-1 und die entsprechenden Antipeptid-Antikörper
MY109309A (en) Improvements in or relating to somatostatins
DE3781250D1 (de) Verwendung vom "cartilage-inducing faktor b(cif-b)" zur herstellung eines arzneimittels gegen das wachstum von tumoren.
DE69614377D1 (de) Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
AU2308992A (en) Cysteine depleted il-6 muteins
HU895788D0 (en) Process for producing peptides and medical products containing them
ATE97575T1 (de) Verwendung eines polypeptids mit interleukin 2aktivit|t zur herstellung einer zur behandlung von einfachen pleurageschwueren bestimmten pharmazeutischen zusammensetzung.
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
Ziganshin et al. Biologically active peptides isolated from the brain of hibernating ground squirrels
EP0516845A4 (de) Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung.
Shoyah et al. Epitheli
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
CA2089111A1 (en) Smooth muscle mitogen and isolated dna coding therefor
FI912879A0 (fi) Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta
EP0352894A3 (de) Herstellung einer kosmetischen oder pharmazeutischen Zusammensetzung
MX9800686A (es) Nueva proteina hmw humana mp52s.